{"filing":{"accession_number":"0000899923-26-000062","cik":"0000899923","ticker":"MYGN","company_name":"MYRIAD GENETICS INC","form":"8-K","filing_date":"2026-06-23","report_date":null,"primary_document":"mygn-20260617.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/899923/000089992326000062/mygn-20260617.htm"},"events":[{"id":13030,"run_id":11561,"accession_number":"0000899923-26-000062","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Dr. Daniel M. Skovronsky, a member of the Board of Directors, resigned effective immediately on June 17, 2026. The disclosure explicitly states the resignation was not due to disagreement or operational concerns, but the departure of a director is a material governance event affecting the composition of the board and investor assessment of leadership continuity.","company_name":"MYRIAD GENETICS INC","ticker":"MYGN","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10055,"accession_number":"0000899923-26-000062","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Daniel M. Skovronsky, a member of the Board of Directors, resigned effective immediately on June 17, 2026. The disclosure explicitly states the resignation was not due to disagreement or operational concerns, but the departure of a director is a material governance event affecting the composition of the board and investor assessment of leadership continuity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T12:33:39.233156+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10055,"accession_number":"0000899923-26-000062","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"Dr. Daniel M. Skovronsky, a member of the Board of Directors, resigned effective immediately on June 17, 2026. The disclosure explicitly states the resignation was not due to disagreement or operational concerns, but the departure of a director is a material governance event affecting the composition of the board and investor assessment of leadership continuity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T12:33:39.233156+00:00","company_name":"MYRIAD GENETICS INC","ticker":"MYGN","filing_date":"2026-06-23"}]}